Untapped markets in the rising economies are expected to provide lucrative growth opportunities for the market

Market Overview:

The World Acne Medication Market was worth $8,017 million in 2018 and is expected to reach $10,929 million by 2023 at a CAGR of 3.9% from 2018 to 2023. Acne is a long-term skin disease that is caused due to clogged hair follicles, dead skin cells, and oil excreted from the skin. It is characterized by the presence of a considerable number of pimples, whiteheads, blackheads, oily skin, and probably scarring. It commonly affects the skin with a comparatively high number of sweat glands at the upper part of the chest, back, and face. Acne medications are medicines that are indicated for the treatment of acne.

Market Drivers and Restraints:

The rise in the prevalence of acne vulgaris condition, particularly in teenagers and adults drive market growth. Other factors that fuel the market growth include an increase in adoption of skin care products and unhealthy urban lifestyle, which result in acne development. Nevertheless, factors like side effects relating to medicines and the presence of substitute acne treatment options like laser therapies, hamper market growth. Conversely, the development of effective therapeutics with lesser side effects and high potential in untapped markets in the growing economies are estimated to provide top growth opportunities for the market.

To know more, click on the link below:


Report segmented as:

By Therapeutic Class:

  • Retinoids
  • Antibiotics
  • Salicylic acid
  • Benzoyl peroxide
  • Others

By Formulation:

  • Topical medications
  • Oral medications

By Type:

  • Non-inflammatory
  • Inflammatory acne

Geographical Analysis:

Based on geography, the market is segmented across North America, Europe, Asia-Pacific, and LAMEA. North America held the most significant share of the market in 2017, followed by Europe. On the other hand, Asia-Pacific is estimated to lead the market throughout the analysis period, due to high population base, rise in disposable income, and improvement in patient awareness about acne medications.

Important market players:

The major players of this market include Allergan Plc., Nestle S.A. (Galderma S.A.), Johnson & Johnson, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc., GlaxoSmithKline Plc (Stiefel Laboratories, Inc.), Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Valeant Pharmaceuticals International, Inc., Daiichi Sankyo Company, Ltd., Ranbaxy Laboratories Limited, Medicis Pharmaceutical Corporation, Foamix Pharmaceuticals, Prestium Pharma, Inc. and BioPharmX, Inc.

View a sample and decide @ https://www.marketdataforecast.com/market-reports/acne-medication-market/request-sample

The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence, and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: abhishek@marketdataforecast.com

Tel: +1-888-702-9626

Website: https://www.marketdataforecast.com/

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.